Rezūm is a relatively new, minimally invasive approach that utilizes vaporized water to ablate prostatic tissue surrounding the proximal urethra in patients with benign prostatic hyperplasia. However, of the many notable studies involving Rezūm's effectiveness in men, none have documented use of Rezūm in the transgender community. With a growing population of transgender patients in the USA, prostate treatments will be offered for transgender women on a more regular basis. To the best of our knowledge, we introduce the first case of Rezūm being utilized to treat benign prostatic hyperplasia in a patient self-identifying as a woman.
Keywords: Rezūm; benign prostatic hyperplasia; safety; transgender.
Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2024.